LekoskopLekoskop
EN All changes
Medicine recalls and shortages › New approvals › 26 Nov 2025
MHRA approval

inavolisib

Published on 26 Nov 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency
The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive
MHRA announcement ↗ All events: inavolisib

What this means

The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.

Summary

The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.